ALKS analyst estimates
Alkermes (ALKS) analyst ratings, the average price target and its range, and every firm's latest call.
ALKS analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 16, 2026 | Truist Financial | Alkermes reinstated with a Buy at Truist | $55.00 |
| Sep 24, 2026 | Goldman Sachs | Alkermes resumed with a Neutral at Goldman Sachs | $50.00 |
| Jul 28, 2026 | Piper Sandler | Alkermes price target raised to $65 from $43 at Piper Sandler | $65.00 |
| Jul 20, 2026 | Stifel Nicolaus | Alkermes (ALKS) PT Raised to $63 at Stifel | $63.00 |
| Jul 2, 2026 | Mizuho Securities | Alkermes (ALKS) PT Raised to $65 at Mizuho | $65.00 |
| Jun 18, 2026 | Needham | Alkermes (ALKS) PT Raised to $54 at Needham | $54.00 |
| Jun 9, 2026 | RBC Capital | Alkermes (ALKS) PT Raised to $56 at RBC Capital; 'Don't Sleep On The Pipeline' | $56.00 |
| May 6, 2026 | Needham | Alkermes price target raised to $50 from $45 at Needham | $50.00 |
| Feb 26, 2026 | H.C. Wainwright | Alkermes (ALKS) PT Lowered to $43 at H.C. Wainwright | $43.00 |
| Feb 23, 2026 | Wolfe Research | Alkermes initiated with an Outperform at Wolfe Research | $45.00 |
| Oct 28, 2025 | Jefferies | Jefferies on Alkermes (ALKS) Earnings: 'Solid Q3 + FY guide raise' | $56.00 |
| Oct 27, 2025 | Mizuho Securities | Alkermes price target raised to $45 from $40 at Mizuho | $45.00 |
| Oct 23, 2025 | Piper Sandler | Alkermes price target raised to $45 from $38 at Piper Sandler | $45.00 |
| Oct 22, 2025 | RBC Capital | Alkermes price target raised to $47 from $45 at RBC Capital | $47.00 |
| Sep 26, 2025 | RBC Capital | Alkermes upgraded to Outperform from Sector Perform at RBC Capital | $44.00 |
- 15 firms rate ALKS: 12 buy, 2 hold, 1 sell.
- The average price target is $58.29 from 7 analysts, from $50.00 to $65.00.
Updated 2026-11-02 23:59 UTC